Analysis of T cell receptor Vβ usage in the autoimmune sialadenitis of non-obese diabetic (NOD) mice

被引:9
|
作者
Yanagi, K [1 ]
Haneji, N [1 ]
Ishimaru, N [1 ]
Saito, I [1 ]
Hayashi, Y [1 ]
机构
[1] Univ Tokushima, Sch Dent, Dept Pathol, Tokushima 770, Japan
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1997年 / 110卷 / 03期
关键词
V beta usage; autoimmune sialadenitis; NOD mouse; Sjogren's syndrome;
D O I
10.1046/j.1365-2249.1997.4271445.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The NOD mouse develops spontaneous autoimmune sialadenitis besides a well characterized T cell-mediated autoimmune insulitis. We used reverse transcriptase-polymerase chain reaction (RT-PCR) to analyse the repertoire of T cell receptor (TCR) V beta chain genes expressed in the isolated infiltrating cells from affected salivary glands. Immunohistochemical analysis showed that the vast majority of inflammatory infiltrates in the salivary glands were CD4(+)V beta 8(+) and CD4(+)V beta 6(+) T cells, whereas CD8(+) T cells and B220(+) B cells were fewer in number. Predominant expression of the V beta 8 and V beta 6 gene segment was detected in the infiltrating cells in the salivary glands very early, and age-related diversity of TCR V beta gene usage was observed. Single-strand conformation polymorphism (SSCP) analysis demonstrated a strikingly symmetrical distribution of expanded clones in the PCR products of the V beta 8 and V beta 6 gene in the cells infiltrating the salivary glands. Nucleotide sequencing of amplified TCR V beta cDNA revealed that T cell clonotypes had a high incidence of identical clones, indicating that the immune response in NOD sialadenitis is driven by common stimuli. These findings suggest that in spontaneous autoimmune sialadenitis of NOD mice, there may be a restricted usage of TCR V beta elements in the early stage of the autoimmune lesion to recognize self-antigen in organ-specific autoimmune sialadenitis.
引用
收藏
页码:440 / 446
页数:7
相关论文
共 50 条
  • [21] Plasmodium chabaudi chabaudi CR in Non-obese Diabetic (NOD) Mice
    Machado, D. R.
    Guaraldo, A. A.
    Vidal, B. C.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2008, 47 (05): : 150 - 150
  • [22] Selective sympathetic autonomic impairment in non-obese diabetic (NOD) mice
    Gross, Volkmar
    Tank, Jens
    Partke, Hans-Juergen
    Plehm, Ralph
    Diedrich, Andre
    Dacostagon-Calves, Andrey C.
    Jordan, Jens
    Luft, Friedrich C.
    DIABETES, 2007, 56 : A207 - A207
  • [23] RAPID DEVELOPMENT OF RENAL COMPLICATIONS IN NON-OBESE DIABETIC (NOD) MICE
    FUNAKAWA, S
    OGAWA, M
    ITO, H
    TOCHINO, Y
    BIOMEDICAL RESEARCH-TOKYO, 1984, 5 (03): : 291 - 294
  • [24] INSULIN AUTOANTIBODIES IN NON-OBESE DIABETIC (NOD) MICE AND STREPTOZOTOCIN-INDUCED DIABETIC MICE
    MARUYAMA, T
    TAKEI, I
    YANAGAWA, T
    TAKAHASHI, T
    ASABA, Y
    KATAOKA, K
    ISHII, T
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1988, 7 (02): : 93 - 96
  • [25] TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice
    Vosters, J. L.
    Roescher, N.
    Illei, G. G.
    Chiorini, J. A.
    Tak, P. P.
    ORAL DISEASES, 2012, 18 (04) : 365 - 374
  • [26] The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
    Hong, S
    Wilson, MT
    Serizawa, I
    Wu, L
    Singh, N
    Naidenko, OV
    Miura, T
    Haba, T
    Scherer, DC
    Wei, J
    Kronenberg, M
    Koezuka, Y
    Van Kaer, L
    NATURE MEDICINE, 2001, 7 (09) : 1052 - 1056
  • [27] The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
    Seokmann Hong
    Michael T. Wilson
    Isao Serizawa
    Lan Wu
    Nagendra Singh
    Olga V. Naidenko
    Toru Miura
    Tomoku Haba
    David C. Scherer
    Jie Wei
    Mitchell Kronenberg
    Yasuhiko Koezuka
    Luc Van Kaer
    Nature Medicine, 2001, 7 : 1052 - 1056
  • [28] Non-obese diabetic mice hemizygous at the T cell receptor alpha locus are susceptible to diabetes and sialitis
    Elliott, JI
    Altmann, DM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (04) : 953 - 956
  • [29] Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes
    Decallonne, B
    van Etten, E
    Glulietti, A
    Casteels, K
    Overbergh, L
    Bouillon, R
    Mathieu, C
    JOURNAL OF AUTOIMMUNITY, 2003, 20 (03) : 219 - 226
  • [30] Hyperalgesia in non-obese diabetic (NOD) mice:: A role for the inducible bradykinin B1 receptor
    Gabra, BH
    Sirois, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 514 (01) : 61 - 67